Join
Live feed
·
INSIDERFilingvia Quantisnow
Nautilus Biotechnology Inc. logo

Chief Scientist Mallick Parag bought $9,885 worth of shares (13,500 units at $0.73), increasing direct ownership by 0.07% to 20,493,392 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NAUT· Nautilus Biotechnology Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAUT (Nautilus Biotechnology Inc.) and more on Quantisnow.